prednisolone has been researched along with Anosmia in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Anosmia: Complete or severe loss of the subjective sense of smell. Loss of smell may be caused by many factors such as a cold, allergy, OLFACTORY NERVE DISEASES, viral RESPIRATORY TRACT INFECTIONS (e.g., COVID-19), aging and various neurological disorders (e.g., ALZHEIMER DISEASE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyposmia and anosmia are common in COVID-19." | 3.11 | COCOS trial: ( Boek, WM; Boesveldt, S; Kamalski, DMA; Schepens, EJA; Stegeman, I; Stokroos, RJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schepens, EJA | 1 |
| Boek, WM | 1 |
| Boesveldt, S | 1 |
| Stegeman, I | 1 |
| Stokroos, RJ | 1 |
| Kamalski, DMA | 1 |
1 trial available for prednisolone and Anosmia
| Article | Year |
|---|---|
COCOS trial:
Topics: Adrenal Cortex Hormones; Anosmia; COVID-19; COVID-19 Testing; Humans; Olfaction Disorders; Prednisol | 2022 |